Telomerase maintains telomere structure in normal human cells
- PMID: 12887925
- DOI: 10.1016/s0092-8674(03)00550-6
Telomerase maintains telomere structure in normal human cells
Abstract
In normal human cells, telomeres shorten with successive rounds of cell division, and immortalization correlates with stabilization of telomere length. These observations suggest that human cancer cells achieve immortalization in large part through the illegitimate activation of telomerase expression. Here, we demonstrate that the rate-limiting telomerase catalytic subunit hTERT is expressed in cycling primary presenescent human fibroblasts, previously believed to lack hTERT expression and telomerase activity. Disruption of telomerase activity in normal human cells slows cell proliferation, restricts cell lifespan, and alters the maintenance of the 3' single-stranded telomeric overhang without changing the rate of overall telomere shortening. Together, these observations support the view that telomerase and telomere structure are dynamically regulated in normal human cells and that telomere length alone is unlikely to trigger entry into replicative senescence.
Similar articles
-
Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span.Curr Biol. 1998 Feb 26;8(5):279-82. doi: 10.1016/s0960-9822(98)70109-5. Curr Biol. 1998. PMID: 9501072
-
Telomeric 3'-overhang length is associated with the size of telomeres.Exp Gerontol. 2008 Apr;43(4):258-65. doi: 10.1016/j.exger.2008.01.005. Epub 2008 Jan 26. Exp Gerontol. 2008. PMID: 18280685
-
Mass cultured human fibroblasts overexpressing hTERT encounter a growth crisis following an extended period of proliferation.Exp Cell Res. 2000 Sep 15;259(2):336-50. doi: 10.1006/excr.2000.4982. Exp Cell Res. 2000. PMID: 10964501
-
Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.J Biomed Mater Res A. 2015 Dec;103(12):3993-4023. doi: 10.1002/jbm.a.35515. Epub 2015 Aug 14. J Biomed Mater Res A. 2015. PMID: 26034007 Review.
-
Extension of cell life span using exogenous telomerase.Methods Mol Biol. 2007;371:151-65. doi: 10.1007/978-1-59745-361-5_12. Methods Mol Biol. 2007. PMID: 17634580 Review.
Cited by
-
Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications.Genes (Basel). 2016 Jul 18;7(7):38. doi: 10.3390/genes7070038. Genes (Basel). 2016. PMID: 27438857 Free PMC article. Review.
-
From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells.Stem Cell Res Ther. 2012 Nov 20;3(6):47. doi: 10.1186/scrt138. Stem Cell Res Ther. 2012. PMID: 23168092 Free PMC article.
-
Mitochondrial reactive oxygen species trigger hypoxia-inducible factor-dependent extension of the replicative life span during hypoxia.Mol Cell Biol. 2007 Aug;27(16):5737-45. doi: 10.1128/MCB.02265-06. Epub 2007 Jun 11. Mol Cell Biol. 2007. PMID: 17562866 Free PMC article.
-
Telomeres and immunological diseases of aging.Gerontology. 2010;56(4):390-403. doi: 10.1159/000268620. Epub 2009 Dec 17. Gerontology. 2010. PMID: 20016137 Free PMC article. Review.
-
Effect of vector-expressed shRNAs on hTERT expression.World J Gastroenterol. 2005 May 21;11(19):2912-5. doi: 10.3748/wjg.v11.i19.2912. World J Gastroenterol. 2005. PMID: 15902727 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials